Literature DB >> 21744129

Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma.

Hideto Suzuki1, Kazumoto Murata, Takaya Gotoh, Masao Kusano, Hiroshi Okano, Takashi Oyamada, Yoshikazu Yasuda, Masatoshi Imamura, Masatoshi Kudo, Masashi Mizokami, Atsushi Sakamoto.   

Abstract

BACKGROUND: Des-γ-carboxy prothrombin (DCP) is an established tumor marker for hepatocellular carcinoma (HCC), but the precise mechanism of its production remains unknown. We have recently demonstrated that cytoskeletal rearrangement during the phenotypic changes involved in epithelial mesenchymal transition (EMT) plays a crucial role in DCP production through the impairment of vitamin K uptake. However, DCP production in long-lasting severe hypoxic conditions with nutrient deprivation-such as transarterial embolization-remains unknown.
METHODS: We examined the effects of long-lasting hypoxia with nutrient deprivation, as well as the constitutive expression of hypoxia-inducible factor (HIF)-1α, on EMT status, DCP production, and protein synthesis in human hepatoma cell lines by enzyme-linked immunosorbent assay, immunofluorescent studies, and western blotting. Immunohistochemistry findings for DCP, anti-hepatocyte paraffin 1 (Hep Par 1), and vimentin were examined using human resected HCC samples.
RESULTS: Both severe hypoxia with nutrient deprivation and HIF-1α transfection led to the cessation of DCP production, by attenuating protein synthesis through the hypophosphorylation of mammalian target of rapamycin and its effector proteins, indicative of a further phenotypic shift involving impaired liver-specific protein synthesis. In immunohistochemistry, the distribution of DCP- and Hep Par 1-positive HCC cells was mostly similar and vimentin-positive HCC cells were frequently observed in the areas that were negative for Hep Par 1 and/or DCP.
CONCLUSIONS: HCC cells produce DCP when they undergo mild phenotypic changes. However, when HCC cells adopt mesenchymal properties they lose their capacity for protein synthesis, and the production of DCP is attenuated. Building upon our previous works, it appears that DCP could be a unique tumor marker that reflects the stepwise phenotypic changes of HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744129     DOI: 10.1007/s00535-011-0432-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  33 in total

Review 1.  Hypoxia signalling in cancer and approaches to enforce tumour regression.

Authors:  Jacques Pouysségur; Frédéric Dayan; Nathalie M Mazure
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 2.  EMT: when epithelial cells decide to become mesenchymal-like cells.

Authors:  Raghu Kalluri
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

3.  Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Authors:  Y Koike; Y Shiratori; S Sato; S Obi; T Teratani; M Imamura; H Yoshida; S Shiina; M Omata
Journal:  Cancer       Date:  2001-02-01       Impact factor: 6.860

4.  Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern.

Authors:  I Kumagai; T Masuda; S -i. Sato; K Ishikawa
Journal:  Hepatol Res       Date:  2001-07       Impact factor: 4.288

5.  Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.

Authors:  Ryosuke Tateishi; Haruhiko Yoshida; Yutaka Matsuyama; Norio Mine; Yuji Kondo; Masao Omata
Journal:  Hepatol Int       Date:  2007-12-29       Impact factor: 6.047

6.  Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

Authors:  Takahisa Sato; Ryosuke Tateishi; Haruhiko Yoshida; Takamasa Ohki; Ryota Masuzaki; Jun Imamura; Tadashi Goto; Fumihiko Kanai; Shuntaro Obi; Naoya Kato; Shuichiro Shiina; Takao Kawabe; Masao Omata
Journal:  Hepatol Int       Date:  2009-08-06       Impact factor: 6.047

7.  Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro.

Authors:  Yong Luo; Da-Lin He; Liang Ning; Shu-Lin Shen; Lei Li; Xiang Li; Haiyen E Zhau; Leland W K Chung
Journal:  BJU Int       Date:  2006-09-06       Impact factor: 5.588

8.  Hypoxia-induced des-gamma-carboxy prothrombin production in hepatocellular carcinoma.

Authors:  Kazumoto Murata; Hideto Suzuki; Hiroshi Okano; Takashi Oyamada; Yoshikazu Yasuda; Atsushi Sakamoto
Journal:  Int J Oncol       Date:  2010-01       Impact factor: 5.650

Review 9.  Hypoxia-driven selection of the metastatic phenotype.

Authors:  Richard Sullivan; Charles H Graham
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

10.  A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

Authors:  Andrew M Arsham; Jessica J Howell; M Celeste Simon
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

View more
  3 in total

Review 1.  Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.

Authors:  Hao Xing; Cunling Yan; Liming Cheng; Nianyue Wang; Shuyang Dai; Jianyong Yuan; Wenfeng Lu; Zhouchong Wang; Jun Han; Yijie Zheng; Tian Yang
Journal:  Tumour Biol       Date:  2016-10-13

2.  Association of des-γ-carboxy prothrombin production and Sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades.

Authors:  Kazumoto Murata; Akiko Saito; Satoshi Katagiri; Shunichi Ariizumi; Masayuki Nakano; Masakazu Yamamoto
Journal:  J Med Ultrason (2001)       Date:  2017-08-21       Impact factor: 1.314

3.  Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma.

Authors:  Masamichi Hayashi; Suguru Yamada; Nao Takano; Yukiyasu Okamura; Hideki Takami; Yoshikuni Inokawa; Fuminori Sonohara; Nobutake Tanaka; Dai Shimizu; Norifumi Hattori; Mitsuro Kanda; Chie Tanaka; Goro Nakayama; Masahiko Koike; Yasuhiro Kodera
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.